Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C David Mazer

Showing results (21-30 of 282) with videos related to

Pageof 29
Sort By:
European Heart Journal|April 22, 2019
Response to optimizing confidence in systematic reviews through registration and bias minimizationNadine Shehata, Nikhil Mistry, C David Mazer
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 5, 2011
"Seizing" the opportunity to understand antifibrinolytic drugsIrene Lecker, Beverley A Orser, C David Mazer
Cell Metabolism|July 12, 2023
Inflammation and cholesterol at the crossroads of vascular riskSubodh Verma, C David Mazer, Kim A Connelly
JAMA|January 27, 2011
Blood transfusion and cardiac surgeryNadine Shehata, C David Mazer, Kevin E Thorpe
Journal of the American College of Cardiology|January 10, 2019
Anticoagulation Following TAVR: No Clear Answer YetC David Mazer, Deepak L Bhatt, Subodh Verma
Critical Care Medicine|September 2, 2025
Bayesian Probabilities and Thresholds in Meta-Analyses and Randomized Trials in Critical Care ResearchTiago V Pereira, C David Mazer, Bijan Teja
The Lancet. Diabetes & Endocrinology|November 7, 2018
The perils of polyvascular disease in type 2 diabetesSubodh Verma, C David Mazer, Deepak L Bhatt
The New England Journal of Medicine|December 27, 2018
Restrictive versus Liberal Transfusion for Cardiac SurgeryC David Mazer, Richard P Whitlock, Nadine Shehata
Anesthesia and Analgesia|March 17, 2022
The Future of Clinical Trials Methodology: Accomplishments and Challenges AheadDuminda N Wijeysundera, Nikhil Mistry, C David Mazer
Intensive Care Medicine|July 23, 2011
Erythropoietic neuroprotection: Holy Grail or potential to fail?Katerina Pavenski, Gregory M T Hare, C David Mazer
Pageof 29

Showing results (21-30 of 282) with videos related to

Sort By:
Pageof 29
European Heart Journal|April 22, 2019
Response to optimizing confidence in systematic reviews through registration and bias minimizationNadine Shehata, Nikhil Mistry, C David Mazer
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 5, 2011
"Seizing" the opportunity to understand antifibrinolytic drugsIrene Lecker, Beverley A Orser, C David Mazer
Cell Metabolism|July 12, 2023
Inflammation and cholesterol at the crossroads of vascular riskSubodh Verma, C David Mazer, Kim A Connelly
JAMA|January 27, 2011
Blood transfusion and cardiac surgeryNadine Shehata, C David Mazer, Kevin E Thorpe
Journal of the American College of Cardiology|January 10, 2019
Anticoagulation Following TAVR: No Clear Answer YetC David Mazer, Deepak L Bhatt, Subodh Verma
Critical Care Medicine|September 2, 2025
Bayesian Probabilities and Thresholds in Meta-Analyses and Randomized Trials in Critical Care ResearchTiago V Pereira, C David Mazer, Bijan Teja
The Lancet. Diabetes & Endocrinology|November 7, 2018
The perils of polyvascular disease in type 2 diabetesSubodh Verma, C David Mazer, Deepak L Bhatt
The New England Journal of Medicine|December 27, 2018
Restrictive versus Liberal Transfusion for Cardiac SurgeryC David Mazer, Richard P Whitlock, Nadine Shehata
Anesthesia and Analgesia|March 17, 2022
The Future of Clinical Trials Methodology: Accomplishments and Challenges AheadDuminda N Wijeysundera, Nikhil Mistry, C David Mazer
Intensive Care Medicine|July 23, 2011
Erythropoietic neuroprotection: Holy Grail or potential to fail?Katerina Pavenski, Gregory M T Hare, C David Mazer
Pageof 29